Skye Bioscience's total assets for Q4 2025 were $28.31M, a decrease of -31.48% from the previous quarter. SKYE total liabilities were $8.29M for the fiscal quarter, a -2.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.